e-ISSN: 2322-0139 p-ISSN: 2322-0120
Topical Dosage Forms of different Drugs by FDA: A Bioequivalence Study
The absorption rate of the test drug doesn't demonstrate a huge difference from the rate of absorption of the reference drug when administered at the same therapeutic dose of the active ingredient under comparable test conditions. The Pharmaceutical Development section gives a chance to present the information from the application of scientific approaches and risk management and from manufacturing process. First it as created for the original marketing application and second updated to support new information gained over the product lifecycle. The Pharmaceutical Development section is intended to provide a more extensive comprehension of the product and manufacturing process for analysts.
Satya Varali
To read the full article Download Full Article | Visit Full Article